Mariam Shallak

Varese, 21100, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 17 publications

The HTLV-1 HBZ Oncoprotein and Its Role in Adult T-Cell Leukemia/Lymphoma.

The HTLV-1 HBZ Oncoprotein and Its Role in Adult T-Cell Leukemia/Lymphoma.

Journal: Cancers

Published: June 09, 2026

HTLV-1 HBZ inhibits DHX9 to reprogram circRNA biogenesis in ATLL.

HTLV-1 HBZ inhibits DHX9 to reprogram circRNA biogenesis in ATLL.

Journal: Tumour virus research

Published: March 17, 2026

New concepts for glioblastoma vaccine immunotherapy.

New concepts for glioblastoma vaccine immunotherapy.

Journal: Biomedical journal

Published: January 05, 2026

CIITA-modified glioblastomas vaccinate and induce cross-protection against heterologous wild-type glioblastomas.

CIITA-modified glioblastomas vaccinate and induce cross-protection against heterologous wild-type glioblastomas.

Journal: Journal of translational medicine

Published: April 30, 2025

An oncolytic HSV-1 vector induces a therapeutic adaptive immune response against glioblastoma.

An oncolytic HSV-1 vector induces a therapeutic adaptive immune response against glioblastoma.

Journal: Journal of translational medicine

Published: August 01, 2024

A Truncated Isoform of Cyclin T1 Could Contribute to the Non-Permissive HIV-1 Phenotype of U937 Promonocytic Cells.

A Truncated Isoform of Cyclin T1 Could Contribute to the Non-Permissive HIV-1 Phenotype of U937 Promonocytic Cells.

Journal: Viruses

Published: June 11, 2024

Novel vaccination strategies based on optimal stimulation of CD4+ T helper cells for the treatment of oral squamous cell carcinoma.

Novel vaccination strategies based on optimal stimulation of CD4+ T helper cells for the treatment of oral squamous cell carcinoma.

Journal: Frontiers in immunology

Published: February 18, 2024

The NLR member CIITA: Master controller of adaptive and intrinsic immunity and unexpected tool in cancer immunotherapy.

The NLR member CIITA: Master controller of adaptive and intrinsic immunity and unexpected tool in cancer immunotherapy.

Journal: Biomedical journal

Published: June 21, 2023

Protective anti-tumor vaccination against glioblastoma expressing the MHC class II transactivator CIITA.

Protective anti-tumor vaccination against glioblastoma expressing the MHC class II transactivator CIITA.

Journal: Frontiers in immunology

Published: December 28, 2022

Mucosal immune response after the booster dose of the BNT162b2 COVID-19 vaccine.

Mucosal immune response after the booster dose of the BNT162b2 COVID-19 vaccine.

Journal: EBioMedicine

Published: June 07, 2022

A Panel of Eight miRNAs Is Deregulated in HTLV-2 Infected PBMCs and BJABGu Cell Line.

A Panel of Eight miRNAs Is Deregulated in HTLV-2 Infected PBMCs and BJABGu Cell Line.

Journal: International journal of molecular sciences

Published: June 06, 2022

The endogenous HBZ interactome in ATL leukemic cells reveals an unprecedented complexity of host interacting partners involved in RNA splicing.

The endogenous HBZ interactome in ATL leukemic cells reveals an unprecedented complexity of host interacting partners involved in RNA splicing.

Journal: Frontiers in immunology

Published: May 09, 2022

Showing 1-12 of 17

Last Updated: 09/26/2026